Skip to main content
SpringerLink
Log in

Renal Effects of Gentamicin in Chronic Bile Duct Ligated Rats

  • Pancreatic and Biliary Disorders
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

Patients with advanced cirrhosis and rats with short-term bile duct ligation (BDL) are prone to develop nephrotoxicity from aminoglycosides. In this study, we characterized the renal response to gentamicin in rats with chronic BDL. BDL and sham-operated (SO) rats were given gentamicin (20 and 40 mg/kg/d) for 7 consecutive days, starting on the 18th postoperative day. Administration of gentamicin to SO group caused a decrease in cortical and medullary prostaglandin E2(PGE2) generation. However, mild reduction in creatinine clearance and an increase in fractional excretion of sodium occurred only in the BDL rats given the high gentamicin dose. This was accompanied by a reduction in cortical and medullary PGE2 generation and a reduction in plasma nitric oxide production. In conclusion, gentamicin administration to rats with chronic BDL causes impairment of renal function. This happens only after the occurrence of simultaneous multiple insults to the renal protective mechanisms.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Caly WR, Strauss E: A prospective study on bacterial infections in patients with cirrhosis. J Hepatol 18:353–358, 1993

    Article  CAS  PubMed  Google Scholar 

  2. Schentag JJ, Plaut ME, Cerra FB, Wels PB, Walczak P, Buckley RJ: Aminoglycoside nephrotoxicity in critically ill surgical patients. J Surg Res 26:270–279, 1979

    Article  Google Scholar 

  3. Smith CR, Lipsky JJ, Laskin OL, et al..: Double blind comparison of the nephrotoxicity and auditory toxicity of gentamicin and tobramycin. N Engl J Med 302:1106–1109, 1980

    CAS  PubMed  Google Scholar 

  4. Moore RD, Smith CR. Lipsky JJ, Mellits ED, Lietman PS: Risk factors for nephrotoxicity in patients treated with aminoglycosides. Ann Intern Med 100:352–357, 1984

    CAS  PubMed  Google Scholar 

  5. Moore RD, Smith CR, Lietman PS: Increased risk of renal dysfunction due to interaction of liver disease and aminoglycosides. Am J Med 80:1093–1097, 1986

    CAS  PubMed  Google Scholar 

  6. Cabrera J, Arroyo V, Ballesta AM, et al..: Aminoglycoside nephrotoxicity in cirrhosis. Gastroenterology 82:97–105, 1982

    CAS  PubMed  Google Scholar 

  7. Felisart J, Rimola A, Arroyo V, et al..: Cefotaxime is more effective than is ampicillin-tobramycin in cirrhotics with severe infections. Hepatology 5:457–462, 1985

    CAS  PubMed  Google Scholar 

  8. Desai TK, Tsang TK: Aminoglycoside nephrotoxicity in obstructive jaundice. Am J Med 85:47–50, 1988

    Article  CAS  PubMed  Google Scholar 

  9. Lucena MI, Andrade RJ, Cabella MR, Hidalgo R, Gonzalez-Correa JA, Sanchez de la Cuesta F: Aminoglycoside associated nephrotoxicity in extrahepatic obstructive jaundice. J Hepatol 22:189–196, 1995

    Google Scholar 

  10. McCormick PA, Greenslade L, Kibbler CC, Chin JKT, Burroughs AK, McIntyre N: A prospective randomized trial of ceftazidime versus netilmicin plus mezlocillin in the empirical therapy of presumed sepsis in cirrhotic patients. Hepatology 25:833–836, 1997

    Article  CAS  PubMed  Google Scholar 

  11. Camps J, Sola X, Rimola A, et al..: Comparative study of aminoglycoside nephrotoxicity in normal rats and rats with experimental cirrhosis. Hepatology 8:837–844, 1988

    CAS  PubMed  Google Scholar 

  12. Zager RA: A focus of tissue necrosis increases renal susceptibility to gentamicin administration. Kidney Int 33:84–90, 1988

    CAS  PubMed  Google Scholar 

  13. Vakil N, Abu-Alfa A, Mujais SK: Gentamicin nephrotoxicity in extrahepatic cholestasis. Modulation by dietary calcium. Hepatology 9:519–524, 1989

    CAS  Google Scholar 

  14. Lucena MI, Gonzalez-Correa JA, Andrade RJ, Ibanez J, Torres D, Sanchez de la Cuesta F: Enhanced gentamicin nephrotoxicity after experimental biliary obstruction in rats. Pharmacol Toxicol 65:352–356, 1989

    Google Scholar 

  15. Vakil NB, Gutkowska J, Abu-Alfa A, Mujais S: Effects of acute and chronic bile duct ligation on plasma atrial natriuretic factor in the rat (abstract). Am J Hypertens 1:135A, 1988

    Google Scholar 

  16. Koepke JP, Jones S, DiBona GF: Renal nerves mediate blunted natriuresis to atrial natriuretic peptide in cirrhotic rats. Am J Physiol 252:R1019–R1023, 1987

    CAS  PubMed  Google Scholar 

  17. Ackerman Z, Karmeli F, Amir G, Rachmilewitz D: Renal vasoactive mediator generation in portal hypertensive and bile duct ligated rats. J Hepatol 24:478–486, 1996

    Article  CAS  PubMed  Google Scholar 

  18. Quarum ML, Houghton DC, Gilbert DN, McCarron DA, Bennett WM: Increasing dietary calcium moderates experimental gentamicin nephrotoxicity. J Lab Clin Med 103:104–114, 1984

    CAS  PubMed  Google Scholar 

  19. Stuehr DJ, Marletta MA: Mammalian nitrite biosynthesis: Mouse macrophages produce nitrite and nitrate in response to Escherichia coli lipopolysaccharide. Proc Natl Acad Sci USA 82:7738–7742, 1985

    CAS  PubMed  Google Scholar 

  20. Bennett WM: Aminoglycoside nephrotoxicity. Nephron 35:73–77, 1983

    CAS  PubMed  Google Scholar 

  21. Glyselynck AM, Forrey A, Cutler R: Pharmacokinetics of gentamicin: Distribution and plasma and renal clearance. J Infect D 124:S70–S76, 1971

    Google Scholar 

  22. Sundin DP, Sandoval R, Molitoris BA: Gentamicin inhibits renal protein and phospholipid metabolism in rats: Implications involving intracellular trafficking. J Am Soc Nephrol 12:114–123, 2001

    CAS  PubMed  Google Scholar 

  23. Laurent G, Kishore BK, Tulkens PM: Aminoglycoside-induced renal phospholipidosis and nephrotoxicity. Biochem Pharmacol 40:2383–2392, 1990

    Article  CAS  PubMed  Google Scholar 

  24. Lipsky JJ, Lietman PS: Aminoglycoside inhibition of renal phosphatidylinosotol phospholipase C. J Pharmacol Exp Ther 220:287–292, 1982

    CAS  PubMed  Google Scholar 

  25. Assael BM, Chiabrando C, Gagliardi L, Noseda A, Bamonte F, Salmona ML: Prostaglandins and aminoglycoside nephrotoxicity. Toxicol Appl Pharmacol 78:386–394, 1985

    Article  CAS  PubMed  Google Scholar 

  26. Vesce F, Pavan B, Buzzi M, et al..: Effect of different classes of antibiotics on amniotic prostaglandin E release. Prostaglandins Other Lipid Mediat 57:207–218, 1999

    CAS  PubMed  Google Scholar 

  27. Piret J, Kishore BK, Tulkens PM: Effect of substrate organization on the activity and on the mechanisms of gentamicin-induced inhibition of rat liver lysosomal phospholipase A-1. Biochem Pharmacol 43:895–898, 1992

    Article  CAS  PubMed  Google Scholar 

  28. Zager RA, Sharma HM, Johannes GA: Gentamicin increases renal susceptibility to an acute ischemic insult. J Lab Clin Med 101:670–678, 1983

    CAS  PubMed  Google Scholar 

  29. Wiest R, Shah V, Sessa WC, Groszmann RJ: NO overproduction by eNOS precedes hyperdynamic splanchnic circulation in portal hypertensive rats. Am J Physiol 276:G1043–G1051, 1999

    CAS  PubMed  Google Scholar 

  30. Niederberger M, Gines P, Martin PY, et al..: Comparison of vascular nitric oxide production and systemic hemodynamics in cirrhosis versus prehepatic portal hypertension in rats. Hepatology 24:947–951, 1996

    CAS  PubMed  Google Scholar 

  31. Cahill PA, Redmond EM, Hodges R, Zhang S, Sitzmann J: Increased endothelial nitric oxide synthase activity in hyperemic vessels of portal hypertensive rats. J Hepatol 25:370–378, 1996

    Article  CAS  PubMed  Google Scholar 

  32. Morales-Ruiz M, Jimenez W, Perez-Sala D, et al..: Increased nitric oxide synthase expression in arterial vessels of cirrhotic rats with ascites. Hepatology 24:1481–1486, 1996

    CAS  PubMed  Google Scholar 

  33. Gadano AC, Songi P, Heller J, Moreau R, Bories PN, Lebrec D: Vascular nitric oxide production during the development of two experimental models of portal hypertension. J Hepatol 30:896–903, 1999

    Article  CAS  PubMed  Google Scholar 

  34. Bech JN, Nielsen CB, Pedersen EB: Effects of systemic nitric oxide synthesis inhibition on renal plasma flow, glomerular filtration rate, urinary sodium excretion and vasoactive hormones in healthy humans. Am J Physiol 270:F845–F851, 1996

    CAS  PubMed  Google Scholar 

  35. Lumsden AB, Henderson MJ, Kutner MH: Endotoxin levels measured by chromogenic assay in portal hepatic and peripheral venous blood in patients with cirrhosis. Hepatology 8:232–236, 1988

    CAS  PubMed  Google Scholar 

  36. Tilz H, Wilmer A, Vogel W, et al..: Serum levels of cytokines in chronic liver diseases. Gastroenterology 103:264–274, 1992

    Google Scholar 

  37. Wilkinson SP, Moodie H, Stamatakis JD, Kakkar VV, Williams R: Endotoxemia and renal failure in cirrhosis and obstructive jaundice. Br Med J 2:1415–1418, 1976

    CAS  PubMed  Google Scholar 

  38. Kocsar LT, Bertok L, Vartereresz V: Effect of bile acids on the intestinal absorption of endotoxin in rats. J Bacteriol 100:220–223, 1969

    CAS  PubMed  Google Scholar 

  39. Stark ME, Szurszewski JH: Role of nitric oxide in gastrointestinal and hepatic function and disease. Gastroenterology 103:1928–1949, 1992

    CAS  PubMed  Google Scholar 

  40. Navasa M, Follo A, Fillella X, et al..: Tumor necrosis factor and interleukin-6 in spontaneous bacterial peritonitis in cirrhosis: Relationship with the development of renal impairment and mortality. Hepatology 27:1227–1232, 1998

    Article  CAS  PubMed  Google Scholar 

  41. Zager RA, Prior RB: Gentamicin and gram negative bacteremia. A synergism for the development of experimental nephrotoxic acute renal failure. J Clin Invest 78:196–204, 1986

    CAS  Google Scholar 

  42. Coopersmith CM, Amiot DM 2nd, Stomberg PE, et al..: Antibiotics improve survival and alter the inflammatory profile in murine model of sepsis from Pseudomonas aeruginosa. pneumonia. Shock 19:408–411, 2003

    CAS  PubMed  Google Scholar 

  43. Tsumura H, Hiyama E, Kodama T, Sueda T, Yokoyama T: Relevance of antimicrobial agent-induced endotoxin release from in vitro cultured Escherichia coli.and in vivo experimental infection with Gram-negative bacilli. Int J Antimicrob Agents 21:463–470, 2003

    CAS  PubMed  Google Scholar 

  44. Rivas-Cabanero L, Rodriguez-Barbero A, Arevalo M, Lopez-Novoa JM: Effect of NG-nitro-arginine methyl ester on nephrotoxicity induced by gentamicin in rats. Nephron 71:203–207, 1995

    CAS  PubMed  Google Scholar 

  45. Zetterstrom R, Ernster L: Bilirubin, an uncoupler of oxidative phosphorylation in isolated mitochondria. Nature 178:1335–1337, 1956

    CAS  PubMed  Google Scholar 

  46. Parkinson TM, Olson JA: Inhibitory effects of bile acids on adenosine triphosphate, oxygen consumption and the transport and diffusion of water soluble substances in the small intestine of the rat. Life Sci 3:107–112, 1964

    Article  CAS  PubMed  Google Scholar 

  47. Weissman G: Studies of lysosomes. VI. The effects of natural steroids and bile acids on lysosomes in vitro. Biochem Pharmacol 14:525–535, 1965

    Google Scholar 

  48. Humes HD: Aminoglycoside nephrotoxicity. Kidney Int 33:900–911, 1988

    CAS  PubMed  Google Scholar 

  49. Leung N, Croatt AJ, Haggard JJ, Grande JP, Nath KA: Acute cholestatic liver disease protects against glycerol-induced acute renal failure in the rat. Kidney Int 60:1047–1057, 2001

    Article  CAS  PubMed  Google Scholar 

  50. Agarwal A, Balla J, Alam J, Croatt AJ, Nath KA: Induction of heme oxygenase in toxic renal injury: A protective role in cisplatin nephrotoxicity in the rat. Kidney Int 48:1298–1307, 1995

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Departments of Medicine, Departments of Mount Scopus, Hadassah Hebrew University Medical Center, Jerusalem, Israel

    Zvi Ackerman MD, Fanny Karmeli BSc & Iddo Ben-Dov MD

  2. Departments of Medicine, Departments of Pathology, Hadassah Hebrew University Medical Center, Jerusalem, Israel

    Galina Pizov MD & Orit Pappo MD

  3. Department of Medicine, Mount Scopus, Hadassah University Hospital, P.O. Box 24035, Jerusalem, 91240, Israel

    Zvi Ackerman MD

Authors
  1. Zvi Ackerman MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Fanny Karmeli BSc
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Galina Pizov MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Iddo Ben-Dov MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Orit Pappo MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Zvi Ackerman MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ackerman, Z., Karmeli, F., Pizov, G. et al. Renal Effects of Gentamicin in Chronic Bile Duct Ligated Rats. Dig Dis Sci 51, 406–415 (2006). https://doi.org/10.1007/s10620-006-3145-8

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10620-006-3145-8

Key Words

Search

Navigation